These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 30870877)
1. Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats. Díaz-Ruano S; López-Pérez AE; Girón R; Pérez-García I; Martín-Fontelles MI; Abalo R J Neurogastroenterol Motil; 2019 Apr; 25(2):300-315. PubMed ID: 30870877 [TBL] [Abstract][Full Text] [Related]
2. Computer vision-based diameter maps to study fluoroscopic recordings of small intestinal motility from conscious experimental animals. Ramírez I; Pantrigo JJ; Montemayor AS; López-Pérez AE; Martín-Fontelles MI; Brookes SJH; Abalo R Neurogastroenterol Motil; 2017 Aug; 29(8):. PubMed ID: 28300332 [TBL] [Abstract][Full Text] [Related]
3. Radiographic dose-dependency study of loperamide effects on gastrointestinal motor function in the rat. Temporal relationship with nausea-like behavior. Vera G; Girón R; Martín-Fontelles MI; Abalo R Neurogastroenterol Motil; 2019 Aug; 31(8):e13621. PubMed ID: 31117152 [TBL] [Abstract][Full Text] [Related]
4. Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat. Vera G; López-Pérez AE; Uranga JA; Girón R; Martín-Fontelles MI; Abalo R Front Pharmacol; 2017; 8():37. PubMed ID: 28220074 [No Abstract] [Full Text] [Related]
5. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors. Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434 [TBL] [Abstract][Full Text] [Related]
6. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417 [TBL] [Abstract][Full Text] [Related]
7. Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration. Maguire DR; Yang W; France CP J Pharmacol Exp Ther; 2013 Jun; 345(3):354-62. PubMed ID: 23536317 [TBL] [Abstract][Full Text] [Related]
8. Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids. Erwin LL; Nilges MR; Denys IB; Sutphen JC; Friend AJ; Kapusta DR; Winsauer PJ Pharmacol Biochem Behav; 2021 Aug; 207():173218. PubMed ID: 34118232 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat. Abalo R; Cabezos PA; Vera G; López-Pérez AE; Martín MI Neurogastroenterol Motil; 2013 May; 25(5):373-82, e292. PubMed ID: 23594243 [TBL] [Abstract][Full Text] [Related]
10. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat. Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133 [TBL] [Abstract][Full Text] [Related]
11. X-ray analysis of gastrointestinal motility in conscious mice. Effects of morphine and comparison with rats. Girón R; Pérez-García I; Abalo R Neurogastroenterol Motil; 2016 Jan; 28(1):74-84. PubMed ID: 26486654 [TBL] [Abstract][Full Text] [Related]
12. Normalization of small intestinal propulsion with loperamide-like antidiarrheals in rats. Megens AA; Canters LL; Awouters FH; Niemegeers CJ Eur J Pharmacol; 1990 Mar; 178(3):357-64. PubMed ID: 2340864 [TBL] [Abstract][Full Text] [Related]
13. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Solinas M; Goldberg SR Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567 [TBL] [Abstract][Full Text] [Related]
14. Is in vivo dissociation between the antipropulsive and antidiarrheal properties of opioids in rats related to gut selectivity? Megens AA; Canters LL; Awouters FH; Niemegeers CJ Arch Int Pharmacodyn Ther; 1989; 298():220-9. PubMed ID: 2569297 [TBL] [Abstract][Full Text] [Related]
15. Establishment of a protocol for determining gastrointestinal transit time in mice using barium and radiopaque markers. Myagmarjalbuu B; Moon MJ; Heo SH; Jeong SI; Park JS; Jun JY; Jeong YY; Kang HK Korean J Radiol; 2013; 14(1):45-50. PubMed ID: 23323030 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of the bifunctional μ- and δ- opioid receptors ligand MCRT on mouse gastrointestinal motility. He C; Li H; Zhang J; Zhou L; Dong S Neuropeptides; 2019 Apr; 74():82-87. PubMed ID: 30738575 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide. Nozaki-Taguchi N; Yaksh TL Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332 [TBL] [Abstract][Full Text] [Related]
18. Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys. Gerak LR; Zanettini C; Koek W; France CP Psychopharmacology (Berl); 2015 Oct; 232(19):3637-47. PubMed ID: 26202613 [TBL] [Abstract][Full Text] [Related]
19. Central orexin-A increases colonic motility in conscious rats. Nozu T; Kumei S; Takakusaki K; Ataka K; Fujimiya M; Okumura T Neurosci Lett; 2011 Jul; 498(2):143-6. PubMed ID: 21575675 [TBL] [Abstract][Full Text] [Related]
20. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat. Abalo R; Cabezos PA; López-Miranda V; Vera G; González C; Castillo M; Fernández-Pujol R; Martín MI Neurogastroenterol Motil; 2009 Sep; 21(9):1002-e80. PubMed ID: 19413685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]